Technical Description
This technology presents the multifunctional compounds with dual cholinesterase inhibition, neuroprotection, metal chelation, antioxidant effects, and Aβ aggregation prevention for Alzheimer’s treatment.
Problems Addressed
- Limited Disease Modification
- Ineffective Aβ Aggregation Inhibition
- Weak Metal Chelation Capability
- Inadequate Neuroprotection
- Restricted Cholinesterase Inhibition
- Absence of Multifunctional Agents
Tech Features
- Efficient Cholinesterase Inhibition
- Enhanced Aβ Disruption
- Optimized Metal Chelation
- Superior Antioxidant Action
- Advanced Neuroprotection
Target Audience
- Pharmaceutical & Drug Development
- Biotechnology & Life Sciences
- Neuroscience & Medical Research
- Healthcare & Clinical Applications
- Academics & Translational Medicine
Tech ID: P27-1321 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
